According to Biodesix's latest financial reports the company has a price-to-book ratio of 30.9.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 36.3 | 325.71% |
2022-12-31 | 8.54 | 17.81% |
2021-12-31 | 7.25 | -44.24% |
2020-12-31 | 13.0 | |
2019-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
LabCorp LH | 2.12 | -93.15% | ๐บ๐ธ USA |
OpGen
OPGN | 2.24 | -92.74% | ๐บ๐ธ USA |
NeoGenomics
NEO | 1.92 | -93.78% | ๐บ๐ธ USA |